Clinical study to evaluate the safety and efficacy of a transcranial electrical stimulation protocol in the treatment of tinnitus.

Multicenter, randomized, controlled, phase 2 and 3 clinical trial to evaluate the safety and efficacy of a transcranial electrical stimulation protocol in the treatment of tinnitus.

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

REBEC

Registry ID

RBR-6hq5qpr

Enrollment

150

Registered

2026-03-15

Start date

2024-06-01

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tinnitus Auditory Perception

Interventions

This is a multicenter, phase 2 and 3, randomized, controlled, sequential (cross-over), double-blind clinical trial to evaluate the safety and validity of transcranial electrical stimulation in the tre

Eligibility

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Be 18 years of age or older; Individuals with hearing loss and a recommendation for hearing aids who complain of tinnitus; Individuals with normal hearing who complain of tinnitus.

Exclusion criteria

Exclusion criteria: Individuals under 18 years of age or incapacitated; Neurological or neurodegenerative disease that interferes with cognitive function; Use of a pacemaker or any other electronic device that may be affected by the use of TEE

Design outcomes

Primary

Measure	Time frame
Transcranial electrical stimulation is expected to be effective in treating tinnitus.	—

Secondary

Measure	Time frame
No secondary outcomes are expected.	—

Countries

Contacts

Public ContactDenise Gonçalves

Universidade Federal de Minas Gerais - Faculdade de Medicina

deniseu85@gmail.com31988872533

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Apr 4, 2026